DK585886D0 - Immunstimulerende middel og anvendelse deraf - Google Patents

Immunstimulerende middel og anvendelse deraf

Info

Publication number
DK585886D0
DK585886D0 DK585886A DK585886A DK585886D0 DK 585886 D0 DK585886 D0 DK 585886D0 DK 585886 A DK585886 A DK 585886A DK 585886 A DK585886 A DK 585886A DK 585886 D0 DK585886 D0 DK 585886D0
Authority
DK
Denmark
Prior art keywords
immunstimental
agents
muramyldipeptide
exhibits
active ingredient
Prior art date
Application number
DK585886A
Other languages
English (en)
Other versions
DK585886A (da
Inventor
Koichiro Ootsu
Giichi Goto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK585886D0 publication Critical patent/DK585886D0/da
Publication of DK585886A publication Critical patent/DK585886A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK585886A 1985-12-24 1986-12-05 Immunstimulerende middel og anvendelse deraf DK585886A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29147185 1985-12-24

Publications (2)

Publication Number Publication Date
DK585886D0 true DK585886D0 (da) 1986-12-05
DK585886A DK585886A (da) 1987-06-25

Family

ID=17769299

Family Applications (1)

Application Number Title Priority Date Filing Date
DK585886A DK585886A (da) 1985-12-24 1986-12-05 Immunstimulerende middel og anvendelse deraf

Country Status (10)

Country Link
US (1) US4780313A (da)
EP (1) EP0228833B1 (da)
JP (1) JPS62228026A (da)
AT (1) ATE66613T1 (da)
AU (1) AU601957B2 (da)
CA (1) CA1285479C (da)
DE (1) DE3681145D1 (da)
DK (1) DK585886A (da)
IL (1) IL80927A0 (da)
PH (1) PH25112A (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643565A (en) * 1985-09-20 1997-07-01 Chiron Corporation Human IL-2 as a vaccine adjuvant
US5503841A (en) * 1985-09-20 1996-04-02 Cetus Oncology Corporation Human IL-2 as a vaccine adjuvant
IL83350A0 (en) * 1986-08-13 1987-12-31 Takeda Chemical Industries Ltd Pharmaceutical compositions comprising interleukin and intterferon active substances
AU603820B2 (en) * 1986-08-13 1990-11-29 Takeda Chemical Industries Ltd. Antitumor agent
US4938956A (en) * 1987-04-01 1990-07-03 International Minerals & Chemical Corp. Synergistic immunostimulating composition and method
DE3881377T2 (de) * 1987-09-02 1993-09-23 Daiichi Seiyaku Co Mittel zur prophylaxe und behandlung von thrombocytopenie.
US4895835A (en) * 1987-11-20 1990-01-23 Nisshin Oil Mills, Ltd. Muramyl peptide derivatives and use thereof
US4950647A (en) * 1988-10-04 1990-08-21 Nucleic Acid Research Institute T cell immunopotentiator
DE3902021A1 (de) * 1989-01-20 1990-07-26 Entec Verwendung von antipeptidergen mitteln, gegebenenfalls in kombination mit anti-androgenen mitteln zur behandlung des humanen prostatakarzinoms
JPH0832638B2 (ja) * 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
CA2066716A1 (en) * 1989-09-25 1991-03-26 Raymond A. Daynes Use of steroid hormones in compositions for inducing t cell lymphokine production
US5250296A (en) * 1990-11-29 1993-10-05 Takeda Chemical Industries, Ltd. Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine
FR2684878B1 (fr) * 1991-12-12 1994-02-11 Roussel Uclaf Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation.
US5258407A (en) * 1991-12-31 1993-11-02 Sterling Winthrop Inc. 3,4-disubstituted phenols-immunomodulating agents
US5449691A (en) * 1991-12-31 1995-09-12 Sterling Winthrop Inc. 3,4-disubstituted anilines-immunomodulating agents
FR2702659B1 (fr) * 1993-03-19 1995-08-25 Vacsyn Sa Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine.
JP3723206B2 (ja) * 1993-03-19 2005-12-07 バクスイン・エス・アー ムラミルペプチドとサイトカインとを組み合わせることを特徴とするヒトに用いる治療用組成物
DE69433013T2 (de) * 1993-05-27 2004-06-03 Entremed, Inc. Zubereitungen und verfahren für die behandlung von krebs und hyperproliferierenden krankheiten
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
US6008319A (en) * 1996-12-23 1999-12-28 University Of Southern California Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
EP1490481A4 (en) * 2001-12-14 2005-12-07 Centocor Inc CLONAL CELL LINES OF MYELOMES FOR PRODUCING PROTEINS IN A CHEMICALLY DEFINED ENVIRONMENT
US20040152170A1 (en) * 2001-12-14 2004-08-05 Lee Chichang Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
US20030166147A1 (en) * 2001-12-14 2003-09-04 Lee Chichang Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン２を含有してなる癌治療剤
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
JPS60115528A (ja) * 1983-11-28 1985-06-22 Takeda Chem Ind Ltd ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物
IL76360A0 (en) * 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins

Also Published As

Publication number Publication date
DE3681145D1 (de) 1991-10-02
EP0228833B1 (en) 1991-08-28
IL80927A0 (en) 1987-03-31
PH25112A (en) 1991-02-19
JPS62228026A (ja) 1987-10-06
EP0228833A3 (en) 1988-12-14
ATE66613T1 (de) 1991-09-15
EP0228833A2 (en) 1987-07-15
AU6618986A (en) 1987-06-25
DK585886A (da) 1987-06-25
CA1285479C (en) 1991-07-02
US4780313A (en) 1988-10-25
AU601957B2 (en) 1990-09-27

Similar Documents

Publication Publication Date Title
DK585886A (da) Immunstimulerende middel og anvendelse deraf
DK175487D0 (da) Farmaceutisk aktive 2-thiomethyl-substitueret-1,4-dihydro-pyridiner
ES554125A0 (es) Procedimiento de preparar hidroxamatos farmaceuticamente activos.
DE3880593D1 (de) Arzneizubereitungen mit retardierter wirkstofffreisetzung.
DK394586A (da) Fungicidt aktive propenoatderivater
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
DK224687D0 (da) Aktive forbindelser
DE69014498D1 (de) Hyposensibilisierende wirksame Substanz.
NO890795L (no) Hudbehandlingspreparat.
BR8602204A (pt) Valvula cardiaca
DK0385279T3 (da) Biologisk aktive midler samt præparater og materialer, der indeholder de biologisk aktive midler
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
DE3682960D1 (de) Pharmazeutische praeparate.
NO870533L (no) Terapeutisk aktive 3-alkoksy-2-aminopropylaminer.
BR8802557A (pt) Agente fisiologicamente ativo para uso agricola
DK394084D0 (da) Fysiologisk aktive praeparater
IT8821300A0 (it) Procedimento di preparazione di morniflumato e analoghi.
DE3675679D1 (de) Menschliche bauchspeichelelastase.
ES552501A0 (es) Procedimiento y dispositivo para esterilizar aparatos o materilaes medicos.
DE3881198D1 (de) Antiviraler wirkstoff.
DK674187D0 (da) Aktive forbindelser
DK511687A (da) Farmaceutisk praeparat, samt fremstilling og anvendelse heraf
FR2587217B1 (fr) Preparations pharmaceutiques immunomodulantes
MX9203658A (es) Derivados de piridobenzoxazina opticamente activos, y su uso antimicrobiano.
IT8519407A0 (it) Preparazioni farmaceutiche, igieniche e presidi medico-chirurgici eloro impiego

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment